Topics: Demand, Microeconomics, Economic Models, Utility, Choice, Demand Curves, Uncertainty, Strategy, Game Theory, Production, Costs, Supply, Profit Maximization, Perfect Competition, General Equilibrium, Welfare, Market Power, Monopoly, Imperfect Competition, Capital, Time, Market Failures, Asymmetric Information, Externalities, Public Goods, Behavioral Economics

Topics: modelling, forecasting, measurement errors, data estimation, general equilibrium models, COMBINING DATA, ANALYTIC TECHNIQUES, Wage-earnings, Company failure, hysteresis

Topics: Public Sector Economics, Public Sector Analysis, Public Sector, Public Finance, Public Goods, Public debts, Public Budget, Public Expenditure, Budgeting, Externalities, Market Failure, Cost-Benefit Analysis

Topics: Pharmacogenomics, Pharmacoepidemiology, DRUG SPECIFICITY, receptor classification, drug concentration, drug effect, spare receptors, COMPETITIVE ANTAGONISM, Irreversible Competitive Antagonism, Partial Agonists, Constitutive Receptor Activation, Inverse Agonists, two-state receptor model, Biased Agonism, Allosteric Modulation, Chemical Antagonism, Pharmacokinetic Antagonism, Receptor–Response Linkage, Physiological Antagonism, Desensitisation, Tolerance, Altered Drug Metabolism, Binding Reaction, Drug–Receptor Interactions, Receptor mechanisms, Ion Channels, Enzymes, Receptor Proteins, Receptor Heterogeneity, Ligand-Gated Ion Channels, Gating Mechanism, G Protein–Coupled Receptors, Proteinase-Activated Receptors, G proteins, phospholipase C, inositol phosphate system, Inositol phosphates, intracellular calcium, Diacylglycerol, protein kinase, MAP kinase system, GPCR desensitisation, Biopharmaceuticals, Chemical Mediators, Presynaptic Modulation, Postsynaptic Modulation, Cholinergic transmission, Nicotinic Receptors, Acetylcholine, Muscarinic Agonists, Muscarinic Antagonists, Ganglion Stimulants, Ganglion-Blocking Drugs, Neuromuscular-Blocking Drugs, Non-Depolarising Blocking Agents, Depolarising Blocking Agents, Cholinesterase Reactivation, Noradrenergic transmission, Adrenoceptor Agonists, α-Adrenoceptor antagonists, 5-Hydroxytryptamine, migraine, Adenosine, purine, Histamine, local hormone, Eicosanoids, Prostanoids, Leukotrienes, Platelet-Activating Factor, Bradykinin, peptide, Neuropeptides, Cytokine, Interferon, Cannabinoids, Endocannabinoids, Nitric oxide, Ischaemic Heart Disease, Antidysrhythmic Drugs, Myocardial Contraction, Anti-Anginal Drugs, Organic Nitrates, Calcium Antagonists, Endothelin, Vasoactive Drugs, Vasodilator Drugs, heart failure, Atherosclerosis, lipoprotein metabolism, Lipoprotein Transport, Lipid-Lowering Drugs, Fibrates, Haemostasis and thrombosis, Blood Coagulation, Warfarin, Platelet Adhesion, Platelet Activation, Antiplatelet Drugs, Adenosine Receptor Antagonists, Fibrinolysis, Thrombolysis, Fibrinolytic Drugs

Topics: Health Care Financing Reforms, Markets, Health Care, health care financing, Funding Health Care, health care systems, health care market failure, Consumer Moral Hazard, Doctor Moral Hazard, Moral Hazard, Countering Consumer Moral Hazard, Countering Doctor Moral Hazard, Equity, Health Care Budget

Topics: Health Economics, Economic Valuation of Life, Economic Valuation of Life Health, Production of Health, Health Goods, Market Failure, Optimal Health Insurance Contracts, Risk Selection in Health Insurance Markets, Medical Services, Hospital Services, Hospital Efficiency, Medical Care, Delivery of Medical Care, Pharmaceuticals, Market for Pharmaceuticals, Political Economy of Health Care, Health Care System

Topics: Small Business Finance, Small Business, Nigerian Financial System, Nigerian Money Market, Nigerian Capital Market, Nigerian Securities and Exchange Commission, central bank of Nigeria, Types of Finance, financing small business, Business Plans, Analysis of Market Opportunities, Failure of Small Business, Success of Small Business, Roles of Small Business in Economic Development

Topics: Entrepreneurship, practicing Entrepreneurship, Entrepreneurial Mindset, Creating Opportunities, Developing Opportunities, Creating New Opportunities, Recognizing New Opportunities, Design Thinking, Building Business Models, Business Models, Developing Customers, Testing, Experimenting, Developing Networks, Building Teams, Evaluating on Opportunities, Acting on Opportunities, Creating Revenue Models, Planning for Entrepreneurs, planning, Anticipating Failure, Bootstrapping, Crowdfunding, Financing Startups, Financial Statements, stratup Projections, Engaging Customers, Marketing, Social Entrepreneurship

Topics: Decision Support Systems, Information Systems, Decision-Making Process, decisions, knowledge, Decision Making, Sensemaking, Data Quality, Decision Makers, Decision Support, Knowledge Management, Integrated Document Management, Online Analytical Processing, Spreadsheet-Based Decision Support Systems, Multi-Criteria Decision Support, Web-Based Decision Support, MULTIPARTICIPANT DECISION SUPPORT SYSTEMS, Group Decision Support Systems, Organizational Decision Support Systems, Negotiation Support, E-negotiation Systems, INTELLIGENT DECISION SUPPORT SYSTEMS, Artificial Neural Networks, Data Mining, Data Fusion, Enhanced Decision Support, Adaptive Decision Support Systems, COMPUTER-BASED DECISION SUPPORT, Decision Support Systems Failure

Topics: Clinical Immunology, immunological techniques, immune regulation, Immunodeficiency Diseases, autoimmunity, Chronic Lymphocytic Leukemia, HIV infections, cardiac disease, chest disease, tuberculosis, gastrointestinal disease, liver disease, endocrine disease, Immune-Mediated Neurological Syndromes